ICD-10 Coding for Methamphetamine Use(F15.10, F15.10U, F15.2)
Explore ICD-10 coding for methamphetamine use, including codes F15.20 and F15.21. Learn documentation requirements and coding tips.
Complete code families applicable to Methamphetamine Use
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| F15.20 | Other stimulant use, uncomplicated | Use when documenting active methamphetamine use without complications. |
|
| F15.21 | Other stimulant use, in remission | Use when documenting methamphetamine use in sustained remission. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutMethamphetamine Use
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Methamphetamine Use.
Failing to document remission status.
Impact
Clinical: Inaccurate patient history., Regulatory: Potential for audit issues., Financial: May affect reimbursement rates.
Mitigation
Regularly update patient records with remission status., Use structured templates for documentation.
Confusing methamphetamine use with abuse or dependence.
Impact
Reimbursement: Incorrect coding can lead to denied claims., Compliance: Misclassification may result in compliance issues., Data Quality: Affects the accuracy of patient records and data reporting.
Mitigation
Carefully review DSM-5 criteria and patient history to determine the correct classification.
Methamphetamine use documentation
Impact
Inadequate documentation of methamphetamine use and remission status.
Mitigation
Implement comprehensive documentation templates and regular training.